Johnson and Johnson

Related Content

News
U.K. Clears Rivaroxaban as First Fixed Dose, Once-Daily Anticoagulant Tablet for Stroke, AF, DVT

January 5, 2011 – Bayer HealthCare's oral anticoagulant tablet Xarelto (rivaroxaban) has been approved for use in the ...

Home January 05, 2012
arrow
News
Rivaroxaban Used in Combination with Standard Therapy Reduced Cardiovascular Death

November 16, 2011 – Johnson & Johnson Pharmaceutical Research & Development announced that adding oral rivaroxaban to ...

Home November 16, 2011
arrow
Technology
Cordis Discontinues Cypher Stent, Halts Development of Nevo Stent

June 16, 2011 — Johnson & Johnson subsidiary Cordis International announced Wednesday that it will cease production of ...

Home June 16, 2011
arrow
News
Rivaroxaban Significantly Reduces Stroke Risk in AF Patients

November 16, 2010 – Results from the ROCKET AF trial showed that rivaroxaban given once daily is superior at reducing ...

Home November 16, 2010
arrow
News
Micrus Joins Codman Neurovascular

October 4, 2010 - Johnson and Johnson has completed the acquisition of Micrus Endovascular, a developer and manufacturer ...

Home October 04, 2010
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now